When Pfizer Inc. Chief Executive Officer Jeffrey Kindler saw that health-care legislation unveiled by House Democratic leaders in October threatened to squeeze drugmakers’ profits, he got on the phone with White House Chief of Staff Rahm Emanuel.
Kindler was upset that the House measure would require pharmaceutical companies to forgo $140 billion in revenue over 10 years, said a person familiar with the discussion.
He wanted assurance from Emanuel that the White House would honor an agreement to limit the drugmakers’ cost to $80 billion.
The deal held.
More at Bloomberg
No comments:
Post a Comment